07:35 AM EDT, 07/29/2024 (MT Newswires) -- GSK (GSK) said Monday that it reached a confidential settlement with Ronald Kimbrow to resolve the Zantac case he filed in Illinois state court.

The company said it does not admit liability, and the case regarding GSK will be dismissed.

Based on 16 epidemiological studies, GSK said there is "no consistent or reliable evidence" that its drug Zantac, or ranitidine, increases cancer risk.

Price: 40.08, Change: +0.22, Percent Change: +0.55